Ermac, Danna L.

HRN: 24-59-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/24/2025
CEFUROXIME 750MG (VIAL)
01/24/2025
01/30/2025
IV
240mg
Q8h
PCAP C
Waiting Final Action 
01/25/2025
CEFTRIAXONE 1G (VIAL)
01/25/2025
02/01/2025
IV
350mg
Q12H
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: